You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Dimenhydrinate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for dimenhydrinate and what is the scope of patent protection?

Dimenhydrinate is the generic ingredient in one branded drug marketed by Baxter Hlthcare, Fresenius Kabi Usa, Watson Labs, Watson Labs Teva, Wyeth Ayerst, Alra, Heather, and Nexgen Pharma Inc, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for dimenhydrinate. One supplier is listed for this compound.

Drug Prices for dimenhydrinate

See drug prices for dimenhydrinate

Recent Clinical Trials for dimenhydrinate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
IWK Health CentrePhase 4
Ciusss de L'Est de l'Île de MontréalN/A
University of British ColumbiaPhase 2/Phase 3

See all dimenhydrinate clinical trials

Medical Subject Heading (MeSH) Categories for dimenhydrinate
Anatomical Therapeutic Chemical (ATC) Classes for dimenhydrinate

US Patents and Regulatory Information for dimenhydrinate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alra DIMENHYDRINATE dimenhydrinate LIQUID;ORAL 080715-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Watson Labs DIMENHYDRINATE dimenhydrinate INJECTABLE;INJECTION 083531-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Fresenius Kabi Usa DIMENHYDRINATE dimenhydrinate INJECTABLE;INJECTION 040519-001 Jun 23, 2004 RX No Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Wyeth Ayerst DIMENHYDRINATE dimenhydrinate INJECTABLE;INJECTION 084316-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.